Journal of Inflammation Research
Volume 16, 2023 - Issue
Open access
119
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
Active Fraction of Polyrhachis Vicina Roger (AFPR) Ameliorate Depression Induced Inflammation Response by FTO/miR-221-3p/SOCS1 Axis
Junhui He1 Department of Pharmacology, Key Laboratory of Quality Standards, Guangxi Institute of Chinese Medicine & Pharmaceutical Science, Nanning, 530022, People’s Republic of ChinaView further author information
, Jiaxiu Xie1 Department of Pharmacology, Key Laboratory of Quality Standards, Guangxi Institute of Chinese Medicine & Pharmaceutical Science, Nanning, 530022, People’s Republic of ChinaView further author information
, Guili Zhou2 Department of Pharmacology, Guangxi Medical University, Nanning, Guangxi, 530021, People’s Republic of China
https://orcid.org/0009-0000-6732-4171View further author information
Chunlian Jia2 Department of Pharmacology, Guangxi Medical University, Nanning, Guangxi, 530021, People’s Republic of ChinaView further author information
, Dongbo Han2 Department of Pharmacology, Guangxi Medical University, Nanning, Guangxi, 530021, People’s Republic of ChinaView further author information
, Dongmei Li1 Department of Pharmacology, Key Laboratory of Quality Standards, Guangxi Institute of Chinese Medicine & Pharmaceutical Science, Nanning, 530022, People’s Republic of ChinaView further author information
, Jie Wei1 Department of Pharmacology, Key Laboratory of Quality Standards, Guangxi Institute of Chinese Medicine & Pharmaceutical Science, Nanning, 530022, People’s Republic of ChinaView further author information
, Yi Li1 Department of Pharmacology, Key Laboratory of Quality Standards, Guangxi Institute of Chinese Medicine & Pharmaceutical Science, Nanning, 530022, People’s Republic of ChinaView further author information
, Renshan Huang1 Department of Pharmacology, Key Laboratory of Quality Standards, Guangxi Institute of Chinese Medicine & Pharmaceutical Science, Nanning, 530022, People’s Republic of ChinaView further author information
, Chunlian Li1 Department of Pharmacology, Key Laboratory of Quality Standards, Guangxi Institute of Chinese Medicine & Pharmaceutical Science, Nanning, 530022, People’s Republic of ChinaView further author information
, Bo Wang3 Guangxi Shuangyi Pharmaceutical Co., Ltd, Nanning, Guangxi, 530021, People’s Republic of ChinaView further author information
, Chao Wei3 Guangxi Shuangyi Pharmaceutical Co., Ltd, Nanning, Guangxi, 530021, People’s Republic of ChinaView further author information
, Qibiao Su4 College of Health Science, Guangdong Pharmaceutical University, Guangzhou, 510006, People’s Republic of ChinaCorrespondence[email protected]
View further author information
, View further author information
Kedao Lai1 Department of Pharmacology, Key Laboratory of Quality Standards, Guangxi Institute of Chinese Medicine & Pharmaceutical Science, Nanning, 530022, People’s Republic of ChinaView further author information
& Guining Wei1 Department of Pharmacology, Key Laboratory of Quality Standards, Guangxi Institute of Chinese Medicine & Pharmaceutical Science, Nanning, 530022, People’s Republic of ChinaCorrespondence[email protected]
View further author information
show allView further author information
Pages 6329-6348
|
Received 07 Oct 2023, Accepted 12 Dec 2023, Published online: 22 Dec 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.